611
Views
37
CrossRef citations to date
0
Altmetric
Original Article

Pharmacological management of the psychiatric aspects of traumatic brain injury

, &
Pages 359-370 | Published online: 11 Jul 2009

References

  • ARANA, G.W. & ROSENBAUM, J.E. (2000). Anti-psychotic drugs. In: G.W. ARANA, & J.F. ROSENBAUM (Eds.), Handbook of Psychiatric Drug Therapy ( pp. 6–52). Philadelphia, PA: Lippincott, Williams and Wilkins.
  • BEERMAN, B. (1993). Side effects of long acting cholines-terase inhibitors. Acta Neurologica Scandinavia Supplement, 149, 53–54.
  • BEETAR, J.D., GutuviErrE, T.J. & SPARADEO, F.R. (1996). Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Archives of Physical Medicine and Rehabilitation, 77, 1298–1302.
  • BERAN, R.G. & GIBSON, R.J. (1998). Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia, 39,280–282.
  • BLEIBERG, J., GARMOE, W., CEDERQUIST, J., et al. (1993). Effects of dexedrine on performance consistency follow-ing brain injury: a double-blind placebo crossover case study. Neuropsychiatiy, Neuropsychology & Behavioral Neurology, 6,245–248.
  • BOYESON, M. & HARMON, R. (1994). Effects of trazodone and despramine on motor recovery in brain injured rats. American Journal of Physical Medicine and Rehabilitation, 72, 286–293.
  • BURKE, J.G., DURSUN, S.M. & REVFI FY, M.A. (1999). Refractory symptomatic schizophrenia resulting from frontal lesion: response to clozapine. Journal of Psychiatry and Neuroscience, 24, 456–461.
  • BURKE, W.J. (2002). Escitalopram. Expert Opinion on Investigational Drugs, 11(10), 1477–1486.
  • BURKE, W.J., GERGEL, I. & BOSE, A. (2002). Fixed dose trial of single isomer SSRI escitalopram in depressed outpatients. Journal of Clinical Psychiatry, 63,331–336.
  • CALABRESE, J.R., BOWDEN, C.L., SACHS, G.S., ASCHER, J.A. MONAGHAN, E. & RUDD, G.D (1999). A double blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Journal of Clinical Psychiatry, 60, 79–88.
  • CHILDERS, M.K. & HOLLAN D. (1997). Psychomotor agitation following gabapentin use in brain injury. Brain Injury, 11(7), 537–540.
  • DAVISON, K. & BAGLEY, C.R. (1969). Schizophrenia like psychosis associated with organic disorders of the central nervous system: a review of literature. In: R.N. HERIUNGTON (Ed.), Current problems in neuro-psychiatry: schizophrenia, epilepsy and the temporal lobe ( pp. 113–184).
  • DINAN, T.G. & MOBAYED, M. (1992). Treatment resistance of depression after head injury: a preliminary study of amitriptyline response. Acta Psychiatrica Scandinavia, 85, 292–294.
  • DOBKIN, B.H. & HANLON, R. (1993). Dopamine against treatment of anterograde amnesia from a mediobasal forebrain injury. Annals of Neurology, 33,313–316.
  • EFRON, D., JARMAN, F. & BARKER, M. (1997). Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind crossover trial. Pediatrics, 100, 1–7.
  • EVANS, R., GAULTIEIU, C. & PATTERSON, D. (1987). Treatment of chronic closed head injury with psycho-stimulant drugs: a controlled case study and an appropriate evaluation procedure. Journal of Nervous and Mental Disorders, 175, 106–109.
  • FANN, J.R., UOMOTO, J.M. & KATON, W.J. (1999). Sertraline in the treatment of major depression following mild traumatic brain injury. Journal of Neuropsychiatiy and Clinical Neurosciences, 12, 226–232.
  • FEDOROFF, J.P., STARKSTEIN, S.E., FORRESTER, A.W., et al. (1992). Depression in patients with acute traumatic brain injury. American Journal of Psychiatry, 149, 918–923.
  • FEENEY, D.M., GONZALEZ, A. & LAW, W.A. (1982). Amphetamine, haloperidol, and experience interact to affect rate of recover after motor cortex injury. Science, 217, 855–857.
  • FLEMINGER, S., GREENWOOD, R.J. & OLIVER, D.L. (2003). Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Systems Review, (1), CD003299.
  • FUGATE, L.P., SPACEK, L.A., KRESTY, L.A., LEVY, C .E., JOHNSON, J.C. & MYSIW, W.J. (1997). Measurement and treatment of agitation following traumatic brain injury: II. A survey of the brain injury special interest group of the American academy of physical medicine and rehabilitation. Archives of Physical Medicine and Rehabilitation, 78(9), 924–928.
  • Fuju, D. & AHMED, I. (2002). Characteristic of psychotic disorder due to traumatic brain injury: an analysis of case studies in the literature. Journal of Neuropsychiany and Clinical Neurosciences, 14, 130–140.
  • GERIUNG, J.P. (1986). Psychiatric sequelae of severe closed head injury. Pediatric Review, 8, 115–121.
  • GLENN, M.B., WROBLEWSKI, B., PARZIALE, J.3 et al. (1989). Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. American journal of Physical Medicine and Rehabilitation, 68, 221–226.
  • GOLDBERG, J.F. (2000). Treatment of bipolar disorders. Psychaitric Clinics of North America Annual of Drug Therapy, 7, 115–149.
  • GRIFFIN, S.L., VAN REEKUM, R. & MASANI C. (2003). A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. Journal of Neuropsychiatry & Clinical Neuroscience, 15(1), 17–26.
  • GUALTIERI, C.T. (1991). Neuropsychiany and Behavioral Pharmacology. New York: Springer-Verlag.
  • GUALTIERI, C.T. (1988). Buspirone: neuropsychiatric effects. Journal of Head Trauma and Rehabilitation, 6, 90–92.
  • GAUTHIER, S., FELDMAN, H., HECKER, J., VELLAS, B., AMES, D., SUBBIAH, P., WHALEN, E.3 EMIR, B., and THE DONEPEZIL MSAD STUDY INVESTIGATORS GROUP. (2002). Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer‘s disease. International Psychogeriatrics, 14(4), 389–404.
  • HINKELDY, N.S. & CORRIGAN, J.D. (1990). The structure of head-injured patients neurobehavioral complaints: preliminary studies. Brain Injury, 4, 115–133.
  • HURLEY, R.A. & TABER, K.H. (2002). Emotional distur-bances following traumatic brain injury. Current Treatment Options in Neurology, 4, 59–75.
  • JORGE, R.E., ROBINSON, R.G. & ARNDT, S. (1993a). Are there symptoms that are specific for depressed mood in patients with traumatic brain injury? Journal of Nervous and Mental Disorders, 181, 91–99.
  • JORGE, R.E., ROBINSON, R.G., STARKESTEIN, S.E., et al. (1993b). Secondary mania following traumatic brain injury. American Journal of Psychiatry, 150, 916–921.
  • JOSEPH, A.B. & WROBLEWSIU, B.A. (1993). Paradoxical akathisia caused by clonazepam, clorazepate and lor-azepam in patients in traumatic encephalopathy and seizure disorders: a subtype of benzodiazepine-induced disinhibition? Behavioral Neurology, 6, 221–223.
  • JOSHI, P., CAPOZZOLI, J.A. & COYLE, J.T. (1985). Effective management with lithium of a persistent, post-traumatic hypomania in a 10-year-old child. Journal of Develop-mental and Behavioral Pediatrics, 6, 352–354.
  • KANE, J.M., MARDER, S.R., SCHOLLER, N.R., et al. (2001). Clozapine and haloperidol in moderately refractory schizophrenia: a six month randomized and double blind comparison. Archives of General Psychiatry, 58, 965–972.
  • KANT, R., DUFFY, J.D. & PIVOVARNIK, A. (1998). The prevalence of apathy following head injury. Brain Injury, 12, 87–92.
  • KATZ, I.R.3 JESTE3 DN., MINTZER, J.E.3 CLYDE, C., NAPOLITANO, J. & BRECHER, M. (1999). Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double blind trial. Risperidone Study Group. Journal of Clinical Psychiatry, 60, 107–115.
  • KECK, P.E. JR. & MCELROY, S.L. ( 2003). Aripiprazole: a partial dopamine D2 receptor agonist anti-psychotic. Expert Opinion on Investigational Drugs, 12(4), 655–662.
  • KOPOPNEN, S., TAIMINEN, T., PoRTDI, R., HIMANEN, L., ISONIEMI, H. & HEINONEN, H., (2002). Axis I and II psychiatric disorders after traumatic brain injury: a 30-year study. American Journal of Psychiatry, 159, 1315–1321.
  • KRAus, M.F. & MARI, P. (1997). The combined use of amantadine and L-dopa/cardidopa in treatment of chronic brain injury. Brain Injury, 11, 455–460.
  • LAL, S., MERBITZ, C.P. & GRWP, J.C. (1988). Modification of function in a head injury patient with Sinemet. Brain Injury, 8, 709–718.
  • LIPSEY, J.R., ROBINSON, R.G., PEARLSON, G.D., RAo, K. & PRICE, T.R. (1984). Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet, 1, 297–300.
  • LEwIN, J. & SUMNERS, D. (1996). Successful treatment of episodic dyscontrol with carbamazepine. British Journal of Psychiatry, 49, 493–499.
  • LISHMAN, W.A. (1968). Brain damage in relation to psychiatric disability after head injury. British Journal of Psychiatry, 114, 373–410.
  • MAHALICK, D., CARMEL, P., GREENBERG, J., et al. (1998). Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatric Neurosurgery, 29, 121–126.
  • MARIN, R.S. (1991). Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiany & Clinical Neurosciences, 3, 243–254.
  • MARKIANOS, M., SERETOS, A., KOLSOU3 A. & CHIUSTOPOULOS, M. (1996). CSF neurotransmitter metabolites in comatose head injury patients during changes in their clinical state. Acta Neurochirurgica (Wien.), 138, 57–59.
  • MASANIC, C.A., BAYLEY, M.T., VANREEKUM, R. & SIMARD, M. (2001). Open-label study of donepezil in traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 82, 896–901.
  • MCALLISTER, T.W. (1992). Neuropsychiatric sequelae of head injuries. Psychiatric Clinics of North America, 15, 395–413.
  • McDowELL, S., WHyTE, J. & D‘EsPosno, M. (1998). Differential effect of a dopaminergic agonist on pre-frontal function in traumatic brain injury patients. Brain, 121, 1155–1164.
  • MICHALS, M.L., CRISMON, M.L., ROBERTS, S. & CHILDS, A. (1993). Clozapine response and adverse effects in nine brain-injured patients. Journal of Clinical Psychopharmacology, 13, 198–203.
  • MULLER, U., MURAI3 T., BAUER-WITMUND, T. & VON CRAMON, D.Y. (1999). Paroxetine versus citalopram tretment of pathological crying after brain injury. Brain Injury, /3, 805–811.
  • MYSIW, W.J. & CLINCHOT, D.M. (1997). Medication to enhance cognitive functioning. Physical Medicine and Rehabilitation Clinics of North America: Pharmacology and Brain Rehabilitation, 11, 781–800.
  • NAHAS, Z., ARLINGHAUS, K.A., KOTRIA, K.J., CLEARMAN, R.R. & GEORGE, M.S. (1998). Neuropsychiatry and Clinical Neurosciences, 10, 453–455.
  • NASRALIAH, H.A., FOWLER, R.C. & JuDD, L.L. (1981). Schizophrenia-like illness following head injury. Psychosomatics, 22, 359–361.
  • NEWBURN, G., EDWARDS, R., THOMAS, H., et al. (1999). Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury. Brain Injury, 13, 352–354.
  • NICKELS, J.L., SCHNEIDER, W.N., DOMBOVY, M.L. &WONG, T.M. (1994). Clinical use of amantadine in brain injury rehabilitation. Brain Injury, 8, 709–718.
  • NIZAMIE, S.H., NIZAMIE, A., BORDE, M. & SHARMA, S. (1988). Mania following traumatic head injury: case reports and neuropsychological findings. Acta Psychiatrica Scandinavia, 77, 637–639.
  • NIH CONSENSUS DEVELOPMENT PANEL ON REHABILITATION OF PERSONS WITH TRAUMATIC BRAIN INJURY (1998). Rehabilitation of persons with traumatic brain injury. Journal of the American Medical Association, 282, 974–983.
  • OWENS, M.J. & RISCH, S.C. (1998). Atypical anti-psycho-tics. In A.F. SCHATZBERG & C.B. NEMEROFF (EdS.), Textbook of Psychopharmacology (pp. 323–348). Washington DC: American Psychiatric Press.
  • PARMELEE, D . X. & 0‘ SHANICK, G. J.(1988) .Carbamazepine-lithium toxicity in brain-damaged adolescents. Brain Injury, 2, 305–308.
  • PERINO, C., RAGO, R., CrcouN A., TORTA, R., & MONACO, F. (2001). Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management. Brain Injury, 15(2), 139–148.
  • PLASSMAN, B.L., HAVLJK R.J., STEFFENS, D.C., HELMS, M.J., NEWMAN, T.N., DROSDICK, D., et al. (2000). Documented head injury in early adulthood and risk of Alzheimer‘s disease and other dementias. Neurology, 55, 1158–1166.
  • POPE, H.G., MCELROY, S.L., SATTIN, A., HUDSON, J.I., KECK, P.E. & KALISH, R. (1988). Head injury, bipolar disorder, and response to valproate. Comprehensive Psychiatry, 29, 34–38.
  • POURCHER, E., FILTEAU, M.J., BOOCHARD, R.H. & BARCH, P. (1994). Efficacy of combinations of buspirone and carbamazepine in early posttraumatic delirium. American Journal of Psychiatry, 151, 150–151.
  • POURCHER, E., BARUCH, P., BOUCHARD, B.H., et al. (1995). Neuroleptic associated tardive dyskinesia in young people with psychosis. British Journal of Psychiatry, 166, 768–772.
  • PRESTON, G.C., WARD, C.E., BROKS, P., et al. (1989). Effects of lorazepam on memory attention and sedation in attention by Ro15-1788. Psychopharmacology, 97, 222–227.
  • RAO, N., JELLINEK, H.M. & WOOLSTON, D.C. (1985). Agitation and closed head injury: haloperidol effects on rehabilitation outcome. Archives of Physical Medicine and Rehabilitation, 66,30–34.
  • RAO, V. & LYKETSOS, C.G. (2000). Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics, 41, 95–103.
  • RAO, V.L., DOGAN, A., TODD, K.G., BOWEN, K.K. & DEMPSEY, R.J. (2001) Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after trau-matic brain injury in rats. Brain Research, 911(1), 96–100.
  • REISBERG, B., DOODY, R., STOFFLER, A., SCHMITT, F., FERRIS, S. & MOBIUS, H.J. (2003). Memantine in moderate-to-severe Alzheimer‘s disease. New England Journal of Medicine, 348(14), 1333–1341.
  • ROBINSON, R.G., SCHULT7, S.K., CASTILLO, C., KOPEL, T., KOSIER, J.T., NEWMAN, R.M., CURDUE, K., PETRACCA, G. & STARKSTEIN, S.E. (2000). Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double blind study. American Journal of Psychiatry, 157, 658–690.
  • ROSLER, M. (2002). The efficacy of cholinesterase inhibi-tors in treating the behavioral symptoms of dementia. International Journal of Clinical Practice, 127, 20–36.
  • SACHDEV, P., SMITH, J.S. & CATHCART, S. (2001). Schizophrenia-like psychosis following traumatic brain injury: a chart-based descriptive and case-control study. Psychological Medicine, 31, 231–239.
  • SALAZAR, A.M., WARDEN, D.L., SCHWAB, K., et al. (2000). Cognitive rehabilitation for traumatic brain injury: a randomized trial. journal of the American Medical Association, 283, 3075–3081.
  • SARAN, A.S. (1985). Depression after mild closed head injury: role of dexamethasone suppression test and antidepressants. Journal of Clinical Psychiatry, 46, 335–338.
  • SCHREIBER, S., KLAG, E., GROSS, Y., SEGMAN, R.H. & PICK, C.G. (1998). Beneficial effects of risperidone on sleep disturbance and psychosis following traumatic brain injury. International Clinical Psychopharmacology, 13, 273–275.
  • SELIGER, G.M., HORNSTEIN, A., FLAX, J., HERBERT, J. & SCHROEDER, K. (1992). Fluoxetine improves emotional incontinence. Brain Injury, 6,267–270.
  • SILVER, J.M. & YUDOFSKY, S.C. (1994). Psychopharma-cology. In: J.M. SILVER, S.C. YUDOFSKY & R.E. HALES (Eds.), Neuropsychiatry of Traumatic Brain Injury (pp. 631–670). Washington, DC: American Psychiatric Press.
  • SLOAN, R.L., BROWN, K.W. & PENTLAND, B. (1992). Fluoxetine as a treatment for emotional lability after brain injury. Brain Injury, 6,315–319.
  • STANISLAV, S.W. (1997). Cognitive effects of anti-psychotic agents in persons with traumatic brain injury. Brain Injury, 11, 335–341.
  • STUART, J.W. & HEMSATTI, R.N. (1988). Bipolar illness following TBI treatment with lithium and carbamaze-pine. Journal of Clinical Psychiatry, 49, 74–75.
  • SuN, Q.Q., Xu, S.S., PAN, J.L. & Guo, W.Q. (1999). Huperzine A capsules enhances memory and learning performance in 34 pairs of matched adolescent students. Acta Pharmacologica Sinica, 20, 601–603
  • TAYLOR, D.M. (2003). Aripiprazole: a review of its pharmacology and clinical use. International Journal of Clinical Practice, 57(1), 49–54.
  • TIUMBLE, M.R. (1987). Anticonvulsant drug and cognitive function: a review of literature. Epilepsia, 28, S37–S45.
  • TIUVEDI, M.. (2001). Flexible dose experience with escitalopram in the treatment of major depressive disorder. Annual meeting of the American College of Neuropsychopharmacology, Waikoloa Village, HI, USA (9–13 December).
  • VAN REEKUM, R., BAYLEY, GARNER, M., S., et al. (1995). N-of-1 study: amantadine for amotivational syndrome in patients with TBI. Brain Injury, 9,49–53.
  • VAN ZOMERAN, A.H. & VAN DEN BURG, W. (1985). Residual complaints of patients two years after severe head injury. journal of Neurology, Neurosurgery & Psychiatry, 48, 21–28.
  • VECHT, C.J., VAN WOEKOM T.C.A.M., TEELKEN, A.W., et al. (1995). Homovanillic acid and 5-hydorxyindole acetic acid cerebrospinal fluid levels. Archives of Neurology, 32, 792–797.
  • WANG, R, ZHANG, H.Y. & TANG, X.C. (2001). Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein (1–40) in rats. European Journal of Pharmacology, 421, 149–156.
  • WANG, L.S., ZHAO, J., SHAO, X.M. & TANG, X.C. (2002). Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia. Brain Research, 949, 162–170.
  • WATKINS, P.B., ZIMMERMAN, H.J., KNAPP, M.J., GRACON, S.I. & LEWIS, K.W. (1994). Hepatoxicity effects of tacrine administration in patients with Alzheimer‘s disease. Journal of the American Medical Association, 271(13), 992.
  • WELLER, M. & KORNHUBER, J. (1993). Amantadine with-drawal and neuroleptic malignant syndrome. Neurology, 43, 2155.
  • WHITLOCK, J.A. (1999). Brain injury, cognitive impairment and donepezil. Journal of Head Trauma and Rehabilitation, 14, 424–427.
  • WILLIAMS, S., RIS, M., AYYANGER, R., SCHEFFT, B. & BEACH, D. (1998). Recovery in pediatric brain injury: is psychostimulant medication beneficial? Journal of Head Trauma and Rehabilitation, 13, 73–81.
  • WiLsoN, B.A. (1997). Cognitive rehabilitation: how it is and how it might be. Journal of International Neuropsychological Society, 3,487–496.
  • WHELAN, F.J., WALKER, M.S. & SCHULTZ, S.K. (2000). Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Annals of Clinical Psychiatry, 12, 131–135.
  • WHYTE, J., HART, T., SCHUSTER, K., FLEMING, M., POLANKY, M. & CosLETT, H. (1997). Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. American journal of Physical Medicine and Rehabilitation, 76,440–450.
  • WHYTE, J., VACCARO, M., GRIEB-NEFF, P. & HART T. (2002). Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. Journal of Head Trauma and Rehabilitation, 17, 284–299.
  • WROBLEWSKI, B.A., MCCOLGAN, K. & SMITH, K. (1990). The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. journal of Clinical Psychopharmacology, 10, 124–128.
  • WROBLEWIU, B.A., JOSEPH, A.B. & CORNBLATT, R.R. (1996). Antidepressant pharmacotherapy and the treat-ment of depression in patients with severe traumatic brain injury: a controlled, prospective study. Journal of Clinical Psychiatry, 57,582–587.
  • WROBLEWSKI, B.A., JOSEPH, A.B., KUPFER, J. & KALLIEL, K. (1997). Effectiveness of valproic acid on destructive and aggressive behaviors in patients with acquired brain injury. Brain Injury, 11, 37–47.
  • XU, S.S., GAO, Z.X., WENG, Z., Du, Z.M., XU, W.A., YANG, J.S., ZHANG, M.L., TONG, Z.H., FANG, Y.S. & CHI, X.S. (1995). Efficacy of tablet huperzine A on memory, cognition and behavior in Alzheimer‘s disease. Acta Pharmacologica Sinica, 16, 391–395.
  • YE, J.W., CM, J.X., WANG, L.M. & TANG, X.C. (1999). Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. Journal of Pharmacology & Experimental Therapeutics, 288, 814–819.
  • ZAFONIE, R.D., MANN, N.R. & FITCHENBERG, N.L. (1996). Sleep disturbance in traumatic brain injury: pharmaco-logical options. Neurorehabilitation, 7, 189–195.
  • ZIMNITZKY, B .M., DEMASO, D . R. & STEINGARD, R. J. (1996). Use of risperidone in psychotic disorder follow-ing ischemic brain damage. Journal of Child and Adolescent Psychopharmacology, 6,75–78.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.